Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markers

1 Apr 2019

Abstract excerpt

PURPOSE: Although both anti-PD-1 antibody and treatments using anti-PD-L1 antibody are currently in clinical use, their therapeutic effects vary according to cancer type. One of the factors accounting for this variability is the expression level of the immune checkpoint molecule that differs between cancer types; thus, it is important to clarify the relationship between clinical outcomes and immune checkpoint...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses
Share to Sarcoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31040694
DOI: 10.2147/ott.s198421

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markersPMID 31040694Read ↗

Development and Validation of a Robust Apoptosis-related Prognostic Classifier in Patients With OsteosarcomaSemantic proximity Read ↗

To construct a prognostic model and identify target gene of macrophage polarization by machine learning for predicting immune responses in osteosarcoma and pan- cancerSemantic proximity Read ↗

Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcomaSemantic proximity Read ↗

Classification of Osteosarcoma Based on Immunogenomic ProfilingSemantic proximity Read ↗

Exploring the immune microenvironment of osteosarcoma through T cell exhaustion-associated gene expression: a study on prognosis predictionSemantic proximity Read ↗

A novel prognostic signature related to programmed cell death in osteosarcomaSemantic proximity Read ↗

Relationship between Osteosarcoma Therapy and Tumorigenesis, Metastasis, Immune Evasion, and ChemoresistanceSemantic proximity Read ↗

A tumor microenvironment-based prognostic index for osteosarcomaSemantic proximity Read ↗

TGF-β signaling pathway-based model to predict prognosis and immunity in osteosarcoma patientsSemantic proximity Read ↗

TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcomaSemantic proximity Read ↗

Profiling targetable immune checkpoints in osteosarcomaSemantic proximity Read ↗

Development of an immune-related prognostic index associated with osteosarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.